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Abstract
Background: The -819C/T polymorphism in interleukin 10 (IL-10) gene has been reported to be associated with inflammatory 
bowel disease (IBD) ,but the previous results are conflicting.
Materials and methods: The present study aimed at investigating the association between this polymorphism and risk of  IBD 
using a meta-analysis.PubMed,Web of  Science,EMBASE,google scholar and China National Knowledge Infrastructure (CNKI) 
databases were systematically searched to identify relevant publications from their inception to April 2016.Pooled odds ratio 
(OR) with 95% confidence interval (CI) was calculated using fixed- or random-effects models.
Results: A total of  7 case-control studies containing 1890 patients and 2929 controls were enrolled into this meta-analysis, and 
our results showed no association between IL-10 gene -819C/T polymorphism and IBD risk(TT vs. CC:OR=0.81,95%CI 0.64-
1.04;CT vs. CC:OR=0.92,95%CI 0.81-1.05; Dominant model: OR=0.90,95%CI 0.80-1.02; Recessive model: OR=0.84,95%CI 
0.66-1.06). In a subgroup analysis by nationality, the -819C/T polymorphism was not associated with IBD in both Asians and 
Caucasians. In the subgroup analysis stratified by IBD type, significant association was found in Crohn’s disease(CD)(CT vs. 
CC:OR=0.68,95%CI 0.48-0.97).
Conclusion: In summary, the present meta-analysis suggests that the IL-10 gene -819C/T polymorphism may be associated 
with CD risk.
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Introduction  
A recent  report revealed that the incidence and preva-
lence of  inflammatory bowel disease (IBD), clinically 
classified into ulcerative colitis (UC) and Crohn’s disease 
(CD), is  increasing with time and in different regions 
around the world, indicating its emergence as a global 
disease1. In Europe the highest annual incidence of  CD 
is 12.7/100000 and UC is 24.3/100000. In Asia and in the 
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Middle East both rates are much lower (CD: 5.0/100000 
and UC: 6.3/100000)1. Little is known about the underly-
ing pathogenesis of  IBD. Several factors such as genetic, 
environmental, immune and infectious factors and their 
interaction contribute to the onset of  IBD2. Many genes 
may be associated with the susceptibility to IBD, includ-
ing  migration inhibitory factor and cytotoxic T lympho-
cyte associated antigen-43,4.
Interleukin 10 (IL-10), primarily produced by monocytes 
and lymphocytes, is a multifunctional cytokine that func-
tions in immune regulation and inflammation5. A previous 
study that during IBD,IL-10 can down-regulate interleu-
kin-1b and TNFa mRNA levels in  peripheral monocytes 
and mononuclear cells of  intestinal lamina propria in 
IBD6. Additionally, a role of  IL-10 in IBD pathogenesis 
was initially suggested by the animal experiment that IL-
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10-deficient mice develop enterocolitis when they are not 
kept in a germ-free environment7. In severe CD and UC 
patients, a defective IL-10 production was identified8.  
The IL-10 gene maps to chromosome 1q31-32.A C-to-T 
single base pair substitution was identified in the promot-
er region of  the IL-10 gene -819 base pairs upstream of  
the transcriptional start site.This single base pair substi-
tution has been named -819C/T9. The most commonly 
studied genetic variants in the IL-10 gene are 3 promoter 
polymorphisms:-592C/A,-819C/T and -1082 G/A10. Re-
cent meta analysis provided evidence for an association 
between IL-10 gene 1082A/G polymorphism and sus-
ceptibility of  IBD11.
In addition to the 1082A/G polymorphism having ef-
fects on IBD susceptibility, there have also been reports 
that the IL-10 gene -819C/T polymorphism is associated 
with IBD. However, these conclusions are inconclusive 
due to insufficient power, small effect and false-positive 
results of  this polymorphism on IBD susceptibility. Me-
ta-analysis is a statistical method that can be used to over-
come the limitations of  individual studies12. Therefore, 
we performed a meta-analysis of  all eligible studies to as-
sess the association of  the IL-10 gene -819C/T polymor-
phism and IBD risk.
Methods
Literature search strategy
Literature databases including PubMed, Web of  
Science,EMBASE,google scholar and China Nation-
al Knowledge Infrastructure (CNKI) databases were 
searched. The search strategy was designed to iden-
tify all possible studies that included the following key 
words:“IL-10 gene”,“inflammatory bowel disease/IBD”, 
“-819C/T”, “single nucleotide polymorphism” and “ge-
netic polymorphism”. All related studies published in 
English language were included. The reference lists of  
the retrieved articles were manually searched. If  more 
than one publication were published using the same data, 
only the study with the largest sample size was included 
in future analysis.
Study selection
The studies included in the meta-analysis had to meet all 
of  the following inclusion criteria: i) case-control studies 
that addressed IBD cases and healthy controls; ii) stud-
ies on the association of  the IL-10 gene -819C/T poly-
morphism and susceptibility to IBD and iii) studies that 
included sufficient genotypic data for extraction. Interim 
analyses, overlapping study populations, animal studies 
and comparisons of  laboratory methods were excluded.
Data extraction
Two investigators retrieved data from the literature based 
on the same inclusion standards and then performed a 
cross-check. Any disagreement was resolved by discussion 
or by a third investigator. The following information was 
recorded for each study: name of  the first author, year of  
publication, country of  study, nationality of  the subjects, 
number of  patients and controls, polymorphisms of  gene 
and evidence of  Hardy- Weinberg equilibrium (HWE).
Statistical analysis
The Hardy-Weinberg equilibrium of  the control group 
was calculated by chi-squared test. P<0.05 was consid-
ered statistically significant. The association between the 
IL-10 gene -819C/T polymorphism and IBD was esti-
mated by calculating pooled OR and 95 %CI under a co 
dominant (TT vs. CC;CT vs. CC), a dominant(TT+CT vs. 
CC), or a recessive model(TT vs. CT+CC).The statistical 
heterogeneity among studies was assessed with I2 statis-
tics.I2 values of  25, 50 and 75% were defined as low, mod-
erate and high estimates, respectively. When I2 > 50% 
indicated heterogeneity across studies, the random effects 
model was used for meta-analysis; otherwise ,the fixed 
effects model was used. When study groups are homo-
geneous, the two models are similar, but if  this is not the 
case the random effects model usually provides wider CIs 
than the fixed effects model. The random effects model is 
best used in the between-study heterogeneity12. 
Subgroup analysis by ethnicity and disease type were per-
formed to examine the source of  heterogeneity. Sensi-
tivity analysis was performed by comparison of  random 
effect model values compared to the fixed effect values. 
The funnel plot asymmetry was assessed by Begg’s test 
and Egger regression asymmetry test to estimate the po-
tential publication bias13.Data analysis was performed 
using STATA version 12 (StataCorp LP,College Station, 
Texas, USA). The power of  each study was computed 
as the probability of  detecting an association between 
the -819C/Tpolymorphism and IBD using a significance 
level of  0.05, assuming an OR of  1.5 (small effect size). 
Power analysis was performed using the statistical pro-
gram PS: Power and Sample Size Calculation (http://bio-
stat.mc.vanderbilt.edu/wiki/Main/PowerSampleSize)14.
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Results
Study characteristics
As shown in Figure 1,8597 491 studies exploring the re-
lationship between IL-10 gene -819C/T polymorphism 
and IBD susceptibility were identified. Finally, a total of  
7 case-control studies met the preset inclusion criteria, 
in which 1890 cases and 2929 controls were included for 
the pooled analysis15-21. The characteristics of  the studies 
are summarized in Table 1. All the studies were published 
in English. The source of  controls was mainly based on 
healthy populations. The HWE test was performed on 
genotype distribution of  the controls were consistent 
with HWE. Six of  7 studies were conducted on Cau-
casian subjects and one study was conducted on Asian 
subjects. In this meta-analysis, there were six CD studies 
and three UC studies investigating the correlation with 
the IL-10 gene -819C/T polymorphism. The statistical 
power of  these 7 studies ranged from 20.4% to 78.5%. 
None of  the included studies had a sufficient statistical 
power exceeding 80%.
Table 1.  Characteristics of the included studies for meta-analysis 












          CC   CT   TT CC   CT   TT CC   CT   TT CC   CT   TT       
Fernandez et al. 2005 Spain Caucasian 470/520 278  159  33 152  70   20 126  89   13 293   185  42 0.10 
Tedde et al. 2008 Italy Caucasian 203/391 127  63   13 127  63   13     / 229   138  24 0.60 
Sanchez et al. 2009 Canada Caucasian 117/94 64   39   14     / 64   39   14 50    37   7 0.27 
Amre et al. 2009 Canada Caucasian 270/336 158  94   15     / 158  94   15 172   132  28 0.71 
Andersen et al. 2010 Denmark Caucasian 336/779 216  111  9     / 216  111  9 483   259  37 0.76 
Ahirwar et al. 2011 India Asian 153/207 42   83   28 31   67   19 11   16   9 61    106  40 0.62 
Wang et al. 2011 New 
Zealand 
Caucasian 341/602 206  121  14     / 206  121  14 365   205  32 0.65 
 
HWE, Hardy–Weinberg equilibrium 
 
 
Figure 1. The flow chart of the included studies in the meta-analysis. 
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Overall meta-analysis and further subgroup analysis
Table 2 lists the main results of  the pooled analysis and 
Figure 2 shows the association of  the IL-10 gene -819C/
T polymorphism with IBD risk in the form of  forest 
plots. In the overall analysis, no significant association 
was found between the risk of  IBD and the IL-10 gene 
-819C/T polymorphism(TT vs. CC:OR=0.81,95%CI 
0.64-1.04;CT vs. CC:OR=0.92,95%CI 0.81-1.05; Domi-
nant model:OR=0.90,95%CI 0.80-1.02;Recessive model: 
OR=0.84,95%CI 0.66-1.06). To assess the potential ef-
fect of  the confounding factors on the overall results, 
we next performed subgroup analyses. When the results 
were stratified according to ethnicity, the -819C/T poly-
morphism was not associated with IBD in either Asians 
or Caucasians (Table 2).In the subgroup analysis strati-
fied by IBD type,a significant association was found in 
CD(CT vs. CC:OR=0.68,95%CI 0.48-0.97).
 
 
Figure 2. Forest plots for the association of -819C/T polymorphism in IL-10 gene with risk of IBD.  
For each study, the estimates of OR and its 95% CI were plotted with a box and a horizontal line.  
The symbol filled diamond indicates pooled OR and its 95% CI. 
  
 
Table 2. Summary of different comparative results. 
 
  N Cases/controls TT vs. CC CT vs. CC Dominant model Recessive model 
Variables     OR(95%CI)   I2 OR(95%CI)   I2 OR(95%CI)   I2 OR(95%CI)   I2 
Total 7 1890/2929 0.81(0.64-1.04)  0.0% 0.92(0.81-1.05)  0.0% 0.90(0.80-1.02)  0.0% 0.84(0.66-1.06)  0.0% 
Ethnicity             
Asian 1 153/207 1.02(0.55-1.89)   / 1.14(0.70-1.85)   / 1.10(0.69-1.76)   / 0.94(0.55-1.60)   / 
Caucasian 6 1737/2722 0.78(0.60-1.02)  0.0%  0.91(0.80-1.04)  0.0%  0.89(0.79-1.01)  0.0% 0.82(0.63-1.06)  0.0% 
Disease type             
UC 3 562/1118 0.86(0.59-1.24)  0.0% 0.84(0.67-1.05)  28.4% 0.90(0.74-1.11)  11.1% 0.95(0.67-1.35)  0.0% 
CD 6 1325/2538 0.75(0.56-1.02)  0.0% 0.68(0.48-0.97)  82.4% 0.78(0.55-1.10)  78.9% 0.79(0.59-1.05)  12.3% 
 
N: number; I2: Inconsistency index; CI: confidence interval; OR: odds ratio. When I2 > 50%, the random effects model was used,or else the fixed effects model was used. 
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Sensitivity analysis and publication bias
Sensitivity analysis was performed to evaluate the stability 
of  the results through random effect model values com-
pared to the fixed effect. By using random effect model, 
the result was not altered, indicating the result of  meta-
analysis was statistically significant. The Begg’s test and 
Egger regression asymmetry test were used to assess the 
publication bias  of  literatures. There was no evidence of  
publication bias in our study (Figure 3 and Figure 4).
 
 




Figure 4. Funnel plot of IL-10 gene -819C/T polymorphism and susceptibility of  
IBD(Egger regression asymmetry test). 
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Discussion
IBD is characterized by immunologically-mediated 
chronic and idiopathic inflammatory conditions of  the 
gastrointestinal tract. The cytokine IL-10 suppresses the 
expression of  Th1-derived cytokines and plays as an im-
portant immune regulator in the intestinal tract22. Cellu-
lar gene therapy remains highly investigational, difficult, 
and expensive23. However the early results are promis-
ing. Lactococcus lactis is a non-pathogenic, non-invasive, 
non-colonizing Gram-positive bacterium, mainly used to 
produce fermented foods24.Steidler et al constructed re-
combinant lactococcus lactis strains for secretion of  bio-
logically active murine IL-10.Using mouse models,they 
showed that Intragastric administration of  IL-10-secret-
ing Lactococcus lactis caused a 50% reduction in colitis 
treated with dextran sulfate sodium and prevented the 
onset of  colitis25.The recent years have brought much 
progress regarding the genetics in IBD and the number 
of  confirmed IBD-associated loci and genes have risen 
dramatically. And some studies suggested that the IL-
10 gene -819C/T polymorphism is associated with IBD 
susceptibility, but the results were inconsistent. These in-
consistent results could be due to a slight effect of  the 
polymorphism on IBD risk or the relatively low statisti-
cal power of  published studies. For this reason, a meta-
analysis approach was needed to provide a quantitatively 
assessment of  the different results.
The present meta-analysis, which included 1890 cases 
and 2929 controls from 7 case-control studies, explored 
the relationship between the -819C/T polymorphism in 
the IL-10 gene and IBD risk. Overall, the subjects and 
controls were matched in age and gender and all stud-
ies were consistent with HWE in control groups. In the 
overall comparison of  pooled ORs, the meta-analysis re-
sults showed no relationship of  the IL-10 gene -819C/T 
polymorphism and the susceptibility to IBD. Subgroup 
analyses were performed according to ethnicity, showed 
no correlation of  the polymorphism with IBD risk both 
in Asians and Caucasians. However, there was only one 
study with Asian subjects, so additional studies that focus 
on Asians should be considered in future analysis. In the 
subgroup analysis stratified by IBD type, a significant as-
sociation was found for CD. The mechanism underlying 
this association is still unclear. This polymorphism might 
be affected via gene-gene and gene-environment interac-
tions. The IL10 promoter polymorphisms G-1082A, C-
819T and C-592A have been most extensively studied. 
They are in tight linkage disequilibrium26.There have been 
reports that G-1082A,-819C/T and C-592A polymor-
phisms can synergistically increased the risk of  IBD19. 
Interaction between other risk factors and the -819C/T 
polymorphism in relation to IBD should be a focus of  
future studies.
There are several limitations in our study, which may af-
fect our conclusions. First, we only included the data from 
published articles in our analyses, and new data from not 
yet published studies may alter our findings. Second, we 
only included the articles written in English, which may 
exclude some relevant articles. Additionally, some studies 
lacked original data and this limited our evaluation of  po-




To the best of  our knowledge, this is the first meta-analy-
sis evaluating the association between the -819C/T poly-
morphism in IL-10 gene and the risk of  IBD.Ourresults 
suggest that the IL-10 gene -819C/T polymorphism may 
be involved with the susceptibility of  CD.Further studies 
should be performed to validate these results.
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